All Editorials articles – Page 20
-
Opinion
Toeing the advertising line
Companies have to tread a little carefully when it comes to advertising prescription drugs
-
Opinion
Chop and change
The UK research landscape is in a state of flux and decisions made now will dictate its direction for many years
-
OpinionFoaming at the reactor mouth
Turning a 1000 gallon reactor into a giant bubble bath is far from soothing, says Chemjobber
-
-
-
-
Opinion
Human capital
Business leader: Incubators and hubs for small and medium-sized enterprises are all the fashion
-
OpinionWhat the market will bear?
Martin Shkreli’s monopolising model poses some uncomfortable questions for the pharma industry, says Derek Lowe
-
OpinionA witches’ brew for trifluoromethylation
Karl Collins is surprised by the difficulty of a seemingly simple alkylation
-
Opinion
A shot in the arm
Vaccines for diseases that afflict the world’s poorest offer an escape not only from disease but also from poverty
-
-
-
OpinionCredit where credit’s due
Disputes over authorship can be a source of conflict in the lab. The solution is greater transparency, says Mark Peplow
-
Opinion
Drugs in a class of their own
New drug types need careful regulation to reward innovation while protecting patients
-
OpinionA shared secret?
Do chemistry and alchemy have a common ancestor, or are they separated by science, asks Philip Ball
-
